Ruvalcaba Syndrome is a rare genetic disorder characterized by physical abnormalities and intellectual disabilities. It is not contagious and cannot be transmitted from person to person. The syndrome is caused by a mutation in the FGD1 gene and is typically inherited in an X-linked recessive pattern. Individuals with Ruvalcaba Syndrome require specialized medical care and support to manage their symptoms and improve their quality of life.
Ruvalcaba Syndrome is a rare genetic disorder that affects multiple systems in the body. It is also known as "Bannayan-Riley-Ruvalcaba Syndrome" (BRRS) or "Ruvalcaba-Myhre-Smith Syndrome" (RMSS). This condition is characterized by various symptoms including macrocephaly (enlarged head), multiple hamartomatous polyps in the intestines, lipomas (benign fatty tumors), and developmental delays.
It is important to note that Ruvalcaba Syndrome is not contagious. It is a genetic disorder caused by mutations in specific genes. These mutations are typically inherited from a parent, but in some cases, they can occur spontaneously. The syndrome follows an autosomal dominant pattern of inheritance, which means that an affected individual has a 50% chance of passing the condition on to their children.
While Ruvalcaba Syndrome is not contagious, it is important to seek medical advice if you suspect you or someone you know may have this condition. A healthcare professional can provide a proper diagnosis and guidance on managing the symptoms and associated health risks. Genetic counseling may also be recommended for individuals and families affected by Ruvalcaba Syndrome to understand the inheritance pattern and make informed decisions.